Kontrol Technologies Announces Fourth Quarter and Fiscal Year 2025 Financial Results
TORONTO–(BUSINESS WIRE)–$KNR #esg—Kontrol Technologies Corp. (CBOE.CA:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol”... Read more.
Kontrol Technologies Announces Fourth Quarter and Fiscal Year 2025 Financial Results
TORONTO–(BUSINESS WIRE)–$KNR #esg—Kontrol Technologies Corp. (CBOE.CA:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol”... Read more.
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc – CNTA
NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &... Read more.
Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. – APLS
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti,... Read more.
McCormick & Co Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of McCormick & Company, Incorporated – MKC
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”)... Read more.
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally CHICAGO–(BUSINESS WIRE)–NielsenIQ (NYSE:NIQ), a... Read more.
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally CHICAGO–(BUSINESS WIRE)–NielsenIQ (NYSE:NIQ), a... Read more.
Accord Financial Announces Fourth Quarter and Fiscal 2025 Financial Results and Amendment to its Banking Facility
TORONTO–(BUSINESS WIRE)–Accord Financial Corp. (TSX – ACD) today released its financial results for the fourth quarter and year ended December 31,... Read more.
Churchill Capital Corp IX Announces Filing of Post-Effective Amendment and Date of Extraordinary General Meeting
SANTA CLARA, Calif. & NEW YORK–(BUSINESS WIRE)–Churchill Capital Corp IX (“Churchill IX”) (NASDAQ: CCIX), a publicly traded special purpose acquisition... Read more.
INVESTOR ALERT: Securities Class Action Filed Against Aldeyra Therapeutics – Investors Encouraged to Contact Kirby McInerney LLP
NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired... Read more.